IFN-driven lipid synthesis shutdown in CD4⁺ T cells during acute SIV infection and persistent OXPHOS with ART

Insights

HIV/SIV infection alters CD4+ T cell metabolism, shutting down fatty-acid synthesis via interferon responses. Antiretroviral therapy initiation broadly suppresses metabolism, but mitochondrial function persists, offering potential therapeutic targets.

Area of Science:

  • Immunology
  • Virology
  • Metabolomics

Background:

  • Cellular metabolism critically influences HIV/SIV replication and the establishment of viral reservoirs.
  • The metabolic reprogramming of CD4+ T cells during HIV/SIV infection and upon antiretroviral therapy initiation (ARTi) in vivo is not well understood.
  • CD4+ T cells are the primary cellular targets for HIV infection.

Purpose of the Study:

  • To comprehensively characterize the metabolic remodeling of CD4+ T cells during SIV infection and ARTi.
  • To investigate the role of type I interferon (IFN-I) responses in metabolic alterations.
  • To explore the potential of targeting metabolic pathways for antiviral and immunomodulatory strategies.

Main Methods:

  • Utilized the SIVmac239 macaque model for in vivo studies.
  • Integrated multi-omics approaches: single-cell metabolic profiling (MIST), transcriptomics, and lipidomics.
  • Employed genome-scale metabolic modeling and functional assays to analyze metabolic pathways.

Main Results:

  • At peak viremia, CD4+ T cells showed suppressed de novo fatty-acid (FA) synthesis, indicated by ACC1 downregulation and reduced membrane phospholipid content.
  • Type I interferon (IFN-I) responses were identified as the driver of FA synthesis shutdown, with IFN-I sufficient to suppress ACC1 in vitro.
  • Pharmacologic inhibition of FA synthesis demonstrated direct antiviral effects by reducing HIV replication and enhancing T cell activation.
  • Following ARTi, metabolic pathways were generally suppressed, but mitochondrial oxidative phosphorylation (OXPHOS) remained elevated.

Conclusions:

  • IFN-driven shutdown of FA synthesis is a key metabolic feature of early HIV/SIV infection.
  • Persistent elevated OXPHOS post-ARTi characterizes the metabolic state during treatment initiation.
  • Targeting FA synthesis and OXPHOS pathways may offer novel strategies to limit viral replication and reservoir formation.